证券代码：002064 证券简称：华峰化学 公告编号：2025-036 华峰化学股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 华峰化学股份有限公司（以下简称"公司"或"本公司"）2024 年度利润 分配方案（以下简称"分配方案"或"权益分配方案"）已获 2025 年 4 月 29 日 召开的 2024 年年度股东大会审议通过，具体如下： 一、股东大会审议通过利润分配的情况 （一）公司 2024 年度利润分配方案为：以公司现有总股本 4,962,543,897 股为基数，向全体股东每 10 股派送现金红利人民币 1.5 元（含税），共用利润 744,381,584.55 元，剩余未分配利润结转下一年度，不以公积金转增股本，该分 配方案符合公司章程规定； （二）自分配方案披露至实施期间公司总股本未发生变化； （三）本次实施的分配方案与公司 2024 年年度股东大会审议通过的分配方 案一致； （四）本次实施分配方案时间未超过公司 2024 年年度股东大会审议通过之 日后的两个月； （五）本次权益分派方案以分配比例不变的 ...

Core Viewpoint - Huafeng Chemical's 19 proposals related to a 6 billion yuan acquisition were collectively rejected, impacting its strategic expansion in the polyurethane industry [1][2]. Group 1: Acquisition and Market Impact - The proposed acquisitions aimed to enhance Huafeng Chemical's product matrix across multiple key segments of the polyurethane industry, facilitating vertical integration from raw materials to end products [2]. - The TPU market is experiencing rapid growth, with a global market size of $3.804 billion in 2023, projected to reach $5.83 billion by 2030, reflecting a CAGR of 6.5% from 2024 to 2030 [2]. Group 2: Competitive Landscape - Major global manufacturers in the TPU sector include BASF, Covestro, Huntsman, Lubrizol, Wanhua Chemical, Huafeng Chemical, and Merck, all actively expanding their production capacities [3]. - Covestro announced a multi-million euro investment in a TPU production base in Zhuhai, Guangdong, aiming for an annual capacity of nearly 120,000 tons [3]. Group 3: Innovations and Applications - The TPU industry is diversifying with innovations such as high-performance paint protection films (PPF) launched by Covestro in collaboration with Shell and others, entering the supply chains of major automotive brands [5]. - The demand for high-quality PPF is rapidly increasing, with consumers seeking enhanced protection features and sustainability [6]. Group 4: Bio-based TPU Developments - Bio-based TPU is emerging as a significant trend, with companies like Wanhua Chemical and BASF developing products from renewable resources, enhancing their competitive edge in sustainability [7][9]. - BASF has initiated a strategy combining product innovation, closed-loop production, and global certification to strengthen its position in the bio-based TPU market [7].

Core Viewpoint - The company reported a decline in revenue and net profit for Q1 2025, but showed significant improvement in net profit compared to the previous quarter, indicating potential recovery in profitability. Financial Performance - In Q1 2025, the company achieved revenue of 6.31 billion yuan, a year-on-year decrease of 5.2% and a quarter-on-quarter decrease of 3.7% [1] - The net profit attributable to shareholders was 500 million yuan, down 26.2% year-on-year but up 145.6% quarter-on-quarter [1] - The net profit after deducting non-recurring items was 460 million yuan, a year-on-year decrease of 29.9% and a quarter-on-quarter increase of 163.1% [1] Product Price and Margin Analysis - In Q1 2025, the price changes for various products were as follows: spandex (-0.8%), adipic acid (-2.7%), and shoe sole raw liquid (-2.6%) [2] - The price spread changes were: spandex (-3.0%), adipic acid (+4.8%), and shoe sole raw liquid (-5.2%) [2] - The company's gross margin was 13.5%, an increase of 5.1 percentage points quarter-on-quarter, while the net margin was 8.0%, up 4.9 percentage points quarter-on-quarter [2] Industry Trends - The spandex industry is experiencing increasing concentration, with significant demand growth expected due to changing consumer preferences and expanding applications [2] - Adipic acid faces short-term profitability pressures due to a mature and competitive domestic market, but long-term growth is anticipated with economic recovery and policy support [3] - The industry is undergoing consolidation, with a focus on quality improvement and integrated supply chains [3] Strategic Moves - The company is progressing with the acquisition of assets from major shareholders, which is expected to enhance its polyurethane industry chain layout [4] - The total transaction value for the acquisition is 6 billion yuan, with a cash payment of 600 million yuan and the issuance of 880 million shares [4] Future Outlook - The company is positioned as a leader in the polyurethane products industry, with ongoing expansion in spandex and stable performance in polyurethane raw liquids [5] - Future net profits are projected to be 2.23 billion yuan in 2025, 3.06 billion yuan in 2026, and 3.62 billion yuan in 2027, indicating a positive growth trajectory [5]

Investment Rating - The investment rating for the company is "Buy" and it is maintained [9] Core Views - The company reported a revenue of 6.31 billion yuan in Q1 2025, a year-on-year decrease of 5.2% and a quarter-on-quarter decrease of 3.7%. The net profit attributable to shareholders was 500 million yuan, down 26.2% year-on-year but up 145.6% quarter-on-quarter. The net profit after deducting non-recurring gains and losses was 460 million yuan, down 29.9% year-on-year but up 163.1% quarter-on-quarter [2][6] - The recovery of the adipic acid price spread supports the company's profitability improvement. In Q1 2025, the company's gross margin was 13.5%, an increase of 5.1 percentage points quarter-on-quarter, and the net profit margin was 8.0%, an increase of 4.9 percentage points quarter-on-quarter [12] - The demand for spandex is expected to maintain high growth due to the increasing concentration in the industry and the expansion of downstream applications. The company is positioned as a leader in the polyurethane products industry in China, focusing on spandex and adipic acid [12] - The profitability of adipic acid is under short-term pressure but remains promising in the long term. The industry is experiencing consolidation and increased quality demands, which may lead to a recovery in the future as economic conditions improve [12] - The major shareholder's asset injection is progressing steadily, which is expected to enhance the company's competitiveness and expand its polyurethane industry chain [12] Summary by Sections Financial Performance - In Q1 2025, the company achieved a revenue of 6.31 billion yuan, a year-on-year decrease of 5.2% and a quarter-on-quarter decrease of 3.7%. The net profit attributable to shareholders was 500 million yuan, down 26.2% year-on-year but up 145.6% quarter-on-quarter. The net profit after deducting non-recurring gains and losses was 460 million yuan, down 29.9% year-on-year but up 163.1% quarter-on-quarter [2][6] Market Dynamics - The spandex industry is seeing increasing concentration, with high growth in demand expected due to evolving consumer preferences and expanding applications. The company is well-positioned to benefit from these trends [12] - The adipic acid market is currently under pressure but is expected to recover in the long term as economic conditions improve and new production capacities are developed [12] Strategic Developments - The major shareholder's asset injection is expected to enhance the company's core competitiveness and expand its industry chain, with the transaction details involving a total consideration of 6 billion yuan [12]

Core Viewpoint - Huafeng Chemical's 2024 annual shareholder meeting did not approve 19 proposals related to the issuance of shares and cash payment for asset purchases and related transactions [1] Group 1: Shareholder Meeting Decisions - The shareholder meeting held on April 29, 2025, rejected proposals including the issuance of shares and cash for asset purchases [1] - A total of 19 proposals were not approved, including those concerning the related transaction report [1] Group 2: Proposed Transactions - Huafeng Chemical plans to acquire 100% equity of Zhejiang Huafeng Synthetic Resin Co., Ltd. and Zhejiang Huafeng Thermoplastic Polyurethane Co., Ltd. from Huafeng Group for a total transaction price of 6 billion yuan [3][4] - The transaction price for Huafeng Synthetic Resin is set at 4.04 billion yuan, while for Huafeng Thermoplastic, it is 1.96 billion yuan [4] Group 3: Valuation and Financial Impact - The assessed value of Huafeng Synthetic Resin's equity is 4.044 billion yuan, showing an increase of 506.96% compared to the book value of 666.39 million yuan [4] - The assessed value of Huafeng Thermoplastic's equity is 1.963 billion yuan, reflecting an increase of 478.49% compared to the book value of 339.37 million yuan [4] Group 4: Transaction Characteristics - The transaction is classified as a related party transaction, with Huafeng Group remaining the controlling shareholder and actual controller post-transaction [4] - The acquisition aims to integrate and extend the industrial chain within the polyurethane industry, enhancing the company's product line and business types [4]

Investment Rating - The investment rating for the basic chemical industry is "Positive (Maintain)" [1] Core Insights - The basic chemical industry achieved a revenue of 23,219.8 billion yuan in 2024, with a year-on-year increase of 3.2%, but a net profit attributable to shareholders of 1,185.6 billion yuan, reflecting a year-on-year decrease of 6.2% [6][35] - In Q1 2025, the industry reported a revenue of 5,602.8 billion yuan, a year-on-year increase of 5.8%, and a net profit of 369.7 billion yuan, which is an increase of 11.8% year-on-year [6][35] - The profitability of the industry showed a sales gross margin of 17.2% in Q1 2025, with a net profit margin of 0.1% [6][35] Summary by Sections Industry Overview - The chemical raw materials and chemical products manufacturing industry saw a revenue of 91,986.4 billion yuan in 2024, with a cumulative year-on-year increase of 4.2%, while total profits decreased by 8.6% [5][26] - Fixed asset investment in the industry increased by 8.6% year-on-year, but the growth rate declined by 4.8 percentage points [5][26] Q1 Performance - In Q1 2025, the basic chemical sector experienced revenue growth, with a year-on-year increase of 5.8% and a net profit increase of 11.8% [6][35] - The sales gross margin for Q1 2025 was 17.2%, reflecting a slight decrease year-on-year but an increase compared to the previous quarter [6][35] Sub-industry Analysis - In 2024, the chlor-alkali and textile chemical products sub-industries showed significant profit growth, with chlor-alkali achieving a net profit growth of 262.8% [40][41] - For Q1 2025, the chlor-alkali sub-industry continued to lead with a net profit growth of 132.2% [41] Key Company Tracking - Major companies in the basic chemical sector, such as Wanhua Chemical and Hualu Hengsheng, reported significant net profit growth in 2024, with many companies experiencing a decrease in capital expenditures [5][6][35]

证券代码：002064 证券简称：华峰化学 公告编号：2025-034 华峰化学股份有限公司 2024年年度股东大会决议公告 本公司及其董事、监事、高级管理人员保证公告内容真实、准确和完 整，并对公告中的虚假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、本次股东大会以现场结合网络投票的方式召开。 2、本次股东大会未通过议案，具体如下： | 序号 | 议案名称 | | --- | --- | | 议案十三 | 关于公司发行股份及支付现金购买资产暨关联交易符合相关法律、法规规定的议案 | | 议案十四 | 关于公司发行股份及支付现金购买资产构成关联交易的议案 | | 议案十五 | 关于公司发行股份及支付现金购买资产暨关联交易方案的议案（本议案为逐项表决） | | 1 | 本次交易方案概述 | | 2 | 发行股票种类、面值及上市地点 | | 3 | 发行方式及发行对象 | | 4 | 发行股份的定价方式和价格 | | 5 | 发行数量 | | 6 | 锁定期安排 | | 7 | 过渡期损益安排 | | 8 | 滚存未分配利润安排 | | 9 | 决议有效期 | | 议案十六 | 关于<华峰化学股份有限公 ...

证券代码：002064 证券简称：华峰化学 公告编号：2025-035 北京海润天睿律师事务所 关于华峰化学股份有限公司 2024 年年度股东大会的法律意见书 本公司及其董事、监事、高级管理人员保证公告内容真实、准确和完 整，并对公告中的虚假记载、误导性陈述或者重大遗漏承担责任。 致：华峰化学股份有限公司 北京海润天睿律师事务所（以下简称"本所"）接受华峰化学股份有限公司 （以下简称"公司"）的委托，指派本所律师出席公司 2024 年年度股东大会（以 下简称"本次股东大会"），并依据《中华人民共和国公司法》（以下简称《公 司法》）《上市公司治理准则》《公司章程》及其他相关法律、法规的规定，就 公司本次股东大会的召集、召开程序、出席会议人员的资格、召集人资格、表决 程序及表决结果等有关事宜出具本法律意见书。 披露媒体上披露《关于召开 2024 年年度股东大会通知公告》（以下简称"原 会议通知"）。 2025 年 4 月 12 日，公司董事会于指定媒体披露《华峰化学股份有限公司 关于延期召开 2024 年年度股东大会暨股东大会补充通知的公告》（与原会议 通知合成"会议通知"），将本次股东大会延期至 2025 年 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [6] Core Views - The company reported Q1 performance that exceeded expectations, with a revenue of 6.314 billion yuan, down 5.15% year-on-year, and a net profit attributable to shareholders of 504 million yuan, down 26.21% year-on-year but up 145.60% quarter-on-quarter [6] - The company is a dual leader in the industries of adipic acid and spandex, maintaining cost advantages and demonstrating resilience in performance during the industry downturn [6][7] - The company is pursuing vertical mergers and acquisitions to strengthen its polyurethane industry position, with a projected net profit of 2.474 billion, 3.110 billion, and 3.822 billion yuan for 2025-2027 [6][8] Financial Summary - In Q1 2025, the average price of adipic acid was 8,106 yuan/ton, down 2.14% quarter-on-quarter, with an average price difference of 2,200 yuan/ton, down 5.06% quarter-on-quarter and down 32.41% year-on-year [7] - The average price of spandex 40D was 23,876 yuan/ton, down 1.01% quarter-on-quarter, with a price difference of 11,083 yuan/ton, down 3.25% quarter-on-quarter and down 12.82% year-on-year [7] - The company plans to acquire 100% equity of Huafeng Synthetic Resin and Huafeng Thermoplastic for a total transaction price of 6 billion yuan, with expected net profits from these assets projected to be 9.67 billion yuan and 6.04 billion yuan respectively from 2025 to 2027 [8] Financial Projections - The company’s revenue projections for 2025-2027 are 27.645 billion, 29.799 billion, and 30.468 billion yuan respectively, with corresponding net profits of 2.474 billion, 3.110 billion, and 3.822 billion yuan [10] - The projected EPS for 2025-2027 is 0.50, 0.63, and 0.77 yuan, with P/E ratios of 13.5, 10.7, and 8.7 respectively [10]

Investment Rating - The report maintains a "Strong Buy" rating for Huafeng Chemical [2][4]. Core Views - The company's Q1 performance was under pressure due to a decline in product prices, with revenue at 6.314 billion yuan, down 5.15% year-on-year, and net profit at 504 million yuan, down 26.21% year-on-year [3]. - Despite short-term challenges, the recovery in spandex prices since 2025 is expected to alleviate operational pressures for spandex manufacturers [3]. - Huafeng Chemical has a strong scale advantage, being the second-largest spandex producer globally and the largest in China, with significant production capacities in adipic acid and polyurethane [3]. - The company is expanding its production capacity, with ongoing projects expected to enhance its scale advantage further [3]. - Investments in upstream raw material projects are anticipated to strengthen the company's cost advantages in the spandex industry [4]. Financial Performance Summary - For 2025, the company forecasts net profits of 2.133 billion yuan, with earnings per share (EPS) of 0.43 yuan, and a price-to-earnings (P/E) ratio of 16 [4][5]. - Revenue is projected to grow from 26.298 billion yuan in 2023 to 33.293 billion yuan in 2027, reflecting a compound annual growth rate (CAGR) of approximately 8.56% [5]. - The net profit is expected to decline slightly in 2025 before recovering in subsequent years, with a forecast of 2.664 billion yuan by 2027 [5]. Company Overview - Huafeng Chemical is a leading manufacturer of spandex fibers, adipic acid, and polyurethane raw materials, with a comprehensive product range that meets diverse customer needs [6]. - The company has established itself as a top player in the chemical fiber industry, recognized for its efficiency and product quality [6].